Snapshot

The Accelerated Approval pathway has been developed by the Taiwan Food and Drug Administration of Taiwan (Chinese Taipei).

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Priority Review: 240 days; Priority + Abbreviated: 150 days